Grith Eng

Zealand University Hospital Køge — Denmark

Medicine · Health Sciences

6h-index134citations14works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(6), Biosimilars and Bioanalytical Methods(6), Monoclonal and Polyclonal Antibodies Research(5), Systemic Lupus Erythematosus Research(4), Spondyloarthritis Studies and Treatments(4)

Publications14 total

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries
Annals of the Rheumatic Diseases·2020· 4 cited
Whole-body Magnetic Resonance Imaging in Axial Spondyloarthritis: Reduction of Sacroiliac, Spinal, and Entheseal Inflammation in a Placebo-controlled Trial of Adalimumab
The Journal of Rheumatology·2018· 39 cited
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
Scandinavian Journal of Rheumatology·2018· 10 cited
Optimizing biological treatment in rheumatoid arthritis with the aid of therapeutic drug monitoring.
PubMed·2016· 6 cited
Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study
PLoS ONE·2016· 33 citedOpen Access
SAT0559 The Anatomical Distribution of Inflammation, Fat, Erosion and New Bone Formation in The Spine Assessed According To The Canada-Denmark MRI Definitions in Patients with Axial Spondyloarthritis
Annals of the Rheumatic Diseases·2016
THU0123 Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry
Annals of the Rheumatic Diseases·2016· 4 cited
FRI0548 Responsiveness of A New MRI Scoring Method Based on The Canada-Denmark Definitions of Lesions in The Spine and The SPARCC MRI Spine Inflammation Index in Patients with Axial Spondyloarthritis
Annals of the Rheumatic Diseases·2016Open Access
AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial
Annals of the Rheumatic Diseases·2016
Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry
2016
Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry
University of Southern Denmark Research Portal (University of Southern Denmark)·2016· 5 cited
Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study
Arthritis·2015· 13 citedOpen Access
Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: A systematic review of cohort studies with focus on dose
Seminars in Arthritis and Rheumatism·2013· 17 cited
THU0197 Presence of Antibodies to Adalimumab and Infliximab in Patients with Rheumatoid Arthritis in Clinical Remission
Annals of the Rheumatic Diseases·2013· 3 cited

Frequent Co-authors

Inge Juul Sørensen(7), Bente Glintborg(5), Anne Gitte Loft(5), Oliver Hendricks(5), Merete Lund Hetland(5), Simon Krabbe(4), Jakob Møllenbach Møller(4), Lone Balding(4), Ole Rintek Madsen(4), Karsten Asmussen(4), Susanne Juhl Pedersen(4), Pierre Bouchelouche(4), Hanne Lindegaard(4), T.M. Kringelbach(4), Nils Bolstad(4), Inger Marie Jensen Hansen(4), Estrid Høgdall(4), Johanna Elin Gehin(4), Christian Enevold(4), Mikkel Østergaard(3)